echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Production Process of 6-(4-(ethoxycarbonyl)piperidin-1-yl)-5-chloropyridine-3-carboxylic acid

    The Production Process of 6-(4-(ethoxycarbonyl)piperidin-1-yl)-5-chloropyridine-3-carboxylic acid

    • Last Update: 2023-05-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The production process of 6-(4-(ethoxycarbonyl)piperidin-1-yl)-5-chloropyridine-3-carboxylic acid involves a series of chemical reactions that convert raw materials into the final product.
    The process can be broken down into several steps, each with its own specific set of conditions and equipment.


    Step 1: Preparation of intermediates
    The first step in the production process is the preparation of the intermediates required for the synthesis of 6-(4-(ethoxycarbonyl)piperidin-1-yl)-5-chloropyridine-3-carboxylic acid.
    This involves a series of reactions that utilize chemical reagents and solvents to convert the raw materials into the desired intermediates.


    Step 2: Condensation reactions
    The second step involves condensation reactions, where the intermediates obtained in step 1 are reacted with each other under specific conditions to form the desired product.
    This step typically involves the use of condensation agents, such as sulfuric acid, and solvents, such as water, to promote the reaction.


    Step 3: Purification of the product
    After the condensation reactions are complete, the product is isolated from the reaction mixture through a series of purification steps.
    This typically involves the use of chromatography techniques, such as column chromatography or high-performance liquid chromatography (HPLC), to separate the product from any remaining impurities.


    Step 4: Characterization of the product
    The final step in the production process involves the characterization of the product to ensure that it meets the desired purity and quality standards.
    This typically involves the use of spectroscopic techniques, such as nuclear magnetic resonance (NMR) spectroscopy or mass spectrometry, to determine the structure and composition of the product.


    In the chemical industry, the production process of 6-(4-(ethoxycarbonyl)piperidin-1-yl)-5-chloropyridine-3-carboxylic acid may vary based on the specific production methods and equipment used by different manufacturers.
    However, the general steps outlined above provide a basic understanding of the production process for this compound.


    It is important to note that the production process of 6-(4-(ethoxycarbonyl)piperidin-1-yl)-5-chloropyridine-3-carboxylic acid involves the use of hazardous chemicals and should be carried out by trained professionals in a controlled environment to minimize the risk of accidents or exposure to hazardous materials.
    Additionally, the production process should adhere to all applicable regulations and standards for environmental protection and safety.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.